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Background: Urinary albumin can be measured in 24 h or spot samples. The 24 h urinary albumin excretion rate is
considered the gold standard, but is cumbersome to collect. Instead, often an overnight sample is collected, and
adjusted for dilution. Proxies for 24 h excretion rate have been studied in diabetics, but seldom in healthy individuals.
Our aims were to compare 24 h and overnight albumin excretion, to assess the impact of personal characteristics, and
to examine correlations between the 24 h excretion rate and proxies such as the albumin to creatinine ratio (ACR).
Methods: Separate 24 h and overnight urine samples were collected from 152 healthy kidney donors. Urinary
creatinine, specific gravity, collection time, and sample volume determined. Differences between 24 h and overnight
samples were examined, and the effects of age, sex, smoking, body mass, glomerular filtration rate, and urinary flow
rate were assessed.
Results: The 24 h albumin excretion rate and ACR were both significantly higher than their overnight counterparts.
Unadjusted albumin was unsurprisingly higher in the more concentrated overnight samples, while concentrations
adjusted for specific gravity were similar. In multivariate analysis, the 24 h excretion rate and proxies were positively
associated with glomerular filtration rate, as was ACR in overnight samples. There were positive associations between
urinary albumin and body mass.
Conclusions: Proxies for the 24 h albumin excretion rate showed relatively high correlations with this gold standard,
but differences due to sampling period, adjustment method, and personal characteristics were large enough to be
worth considering in studies of albumin excretion in healthy individuals.
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The detection and quantification of albumin in urine is
common and important in clinical medical practice. It is
widely used for screening of diabetic and hypertensive
nephropathy, as well as preeclampsia. Microalbuminuria
is also a risk factor for cardiovascular morbidity and
mortality [1-5].* Correspondence: peter.fagerstrom@amm.gu.se
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unless otherwise stated.The urine sample used to measure albumin can be col-
lected during a 24 h period, overnight (ON), or as a spot
urine sample at any time of the day. It is still unclear how
albumin excretion differs between 24 h and ON samples
in a healthy population. The 24 h albumin excretion rate
(AER, mg/h) is considered to be the gold standard, al-
though the need for timed samples is still debated [6-8].
The simpler and therefore more widely used urinary albu-
min concentration (UAC, mg/L) can be adjusted for dilu-
tion, either using urinary creatinine (albumin to creatinine
ratio, ACR, mg/g) or urine specific gravity (SG, albumin
adjusted for specific gravity, ASG, mg/L).tral. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
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diabetes and various other clinical conditions, but there is
a notable lack of studies examining different ways of ex-
pressing albumin excretion in healthy individuals [9,10].
Such information is important, for example, when urinary
albumin is used in epidemiological studies searching for
mild effects on renal function of nephrotoxic drugs or en-
vironmental contaminants, and in studies assessing associ-
ations between U-Alb and risk of cardiovascular disease.
This study had three aims:
1. 24 h sampling vs. overnight sampling: To examine
associations and differences between U-Alb in 24 h and
ON samples measured as AER, UAC, ACR, and ASG.
2. Determinants in healthy subjects: To investigate
how glomerular filtration rate (GFR), sex, age, body
mass, smoking, and urinary flow (UF) affect U-Alb
measured as AER, UAC, ACR, and ASG.
3. Proxies: To investigate how well UAC, ACR, and
ASG in ON samples reflect 24 h AER.
Methods
Study population
Between 1999 and 2005, 152 healthy kidney donors (no
kidney disease or diabetes, and normal GFR) were re-
cruited and examined as previously described [11,12].
Background data on these individuals are shown in
Table 1. Informed consent was obtained from the partic-
ipants. The study adhered to the Declaration of Helsinki
and was approved by the ethical review board of the
University of Gothenburg.
Urine samples and biochemical assays
As previously described, two separate timed urine samples
were collected from each of the participants on two con-





Body mass (lbs) 165 (108–245)
Age 48 (24–70)
GFR (ml/min/1.73 m2) 101 (77.0-147)
24 h samples (n) 130
24 h collection time (hrs) 23.2 (20.5-26.6)
24 h volume (ml) 1878 (444–5790)
ON samples (n) 145
ON collection time (hrs) 8.7 (6.0-14.8)
ON volume (ml) 419 (95–1050)
ain ever-smokers.this collection, 123 participants provided both ON and
24 h samples, 22 provided only an ON sample, and 7 pro-
vided only a 24 h sample. Time since last urination (col-
lection time) and sample volume were recorded (Table 1).
Urinary albumin and creatinine concentrations were
determined at the Department of Clinical Chemistry,
Sahlgrenska University hospital, Gothenburg. Urinary al-
bumin concentrations were determined on fresh samples
by an automated nephelometric immunochemical method
using reagents and calibrator from Beckman Coulter
(Fullerton, CA, USA). Internal reference samples were used
in each analytical run. The detection limit was 2.4 mg/L.
Urinary creatinine concentrations were determined using
the Jaffé method (Roche Diagnostics, GmbH, Mannheim,
Germany) in the first three batches, and an enzymatic
method (Modular P and CREAplus R1, R2, Roche/Hitachi,
Roche Diagnostics, GmbH, Mannheim, Germany) in the
last batch (N = 41). The methods are comparable [13]. In
addition, the laboratory performed internal quality control
measures when introducing the enzymatic method, in order
to ascertain that results were comparable. Specific gravity
was measured with a refractometer (Medline, Ceti, Digit
012, Oxfordshire, UK).
GFR was measured using plasma clearance of iohexol
or Cr-EDTA, except for a few cases where technetium-
99 m-DTPA was used. The methods are comparable as
GFR markers [14].
AER, ACR, ASG, and UF were calculated from the
UAC, sample volume, collection time, specific gravity, and
creatinine concentration. ASG was adjusted to SG = 1.015
according to the formula ASG =U-Alb*(1.015-1)/(specific
gravity-1) [15].
Statistics
UAC values below the detection limit (23 ON samples




14.5 (0.4-51.0) 13.3 (1.2-36.3)
183 (143–245) 150 (108–209)
49 (30–70) 48 (24–64)
99.5 (78-140) 101 (77.0-147)
55 75
23.3 (21.5-26.6) 23.1 (20.5-24.8)
1795 (680–4199) 1938 (444–5790)
63 82
8.7 (6.0-14.8) 8.6 (6.3-11.3)
434 (120-1050) 407 (95–1002)
Table 2 Excretion rates and concentrations of albumin in
24 h and overnight (ON) samples




24 h AER (mg/24 h) 130 7.46 0.88-35.7 <0.001
ON AER (mg/24 h) 145 5.85 0.81-29.6
Albumin concentration
24 h UAC (mg/L) 130 4.30 1.70-22.0 <0.001
ON UAC (mg/L) 145 6.33 1.70-45.0
24 h ACR (mg/g Cr) 130 5.85 1.36-24.3 <0.001
ON ACR (mg/g Cr) 145 4.94 0.83-24.9
24 h ASG (mg/L) 130 4.26 0.67-20.0 0.93
ON ASG (mg/L) 145 4.46 0.98-27.3
Creatinine concentration
24 h UCC (g/L) 130 0.77 0.18-3.94 <0.001
ON UCC (g/L) 145 1.28 0.33-2.49
Specific gravity
24 h SG 130 1.016 0.005-1.038 <0.001
ON SG 145 1.021 1.006-1.040
Urinary flow rate
24 h UF (mL/h) 130 81.2 20.4-246 <0.001
ON UF (mL/h) 145 49.2 11.5-150
Creatinine excretion rate
24 h CER (mg/24 h) 130 11.6 4.69-21.8 <0.001
Overnight CER (mg/24 h) 145 11.0 3.07-19.6
Note: Differences between 24 h and ON samples were calculated for 123
paired samples. Abbreviations: AER Albumin excretion rate, UAC Urinary
albumin concentration, ACR Albumin to creatinine ratio, Cr Creatinine, ASG
Albumin adjusted for specific gravity, UCC Urinary creatinine concentration,
SG Specific gravity, UF Urinary flow.
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formed using version 9.2 of the SAS software package
(SAS Institute, Cary, NC, USA). Several variables were
not normally distributed. Associations between variables
were tested with the Spearman correlation coefficient
and with linear and multiple linear regression analysis.
Differences between 24 h and ON samples were tested
using paired t-tests. Differences between groups were
tested using the Wilcoxon rank sum test. Statistical
significance was determined at P<0.05 (two-tailed). All
multiple regression analyses were performed stepwise
as shown below.
U‐Alb ¼ aþ b1 GFRþ b2  ageþ b3  sex
þ b4  body massþ b5
 smoking never=ever½  þ b6  UF ð1Þ
Results
Albumin excretion rate (AER)
The 24 h albumin excretion rate was significantly higher
than the ON AER (Table 2). The association between
24 h and ON AER is shown in Figure 1.
There was a positive association between GFR and
24 h AER, but not between GFR and ON AER (Table 3).
There was a positive correlation between body mass and
AER in both 24 h and ON samples. There was no signifi-
cant correlation between UF and AER. Men had higher
ON AER than women, but no significant difference
was seen in 24 h AER (Table 4). No difference was
seen between never-smokers and ever-smokers.
In a multiple regression analysis according to Equation 1
the positive association between GFR and the 24 h AER
remained (P = 0.003) but there was no significant association
with ON AER (P = 0.09). Body mass was associated with
ON AER (P = 0.02), but not with 24 h AER (P = 0.06).
Urinary albumin concentration (UAC)
As expected, the 24 h UAC was significantly lower than
UAC in the more concentrated ON samples (Table 2).
The association between ON and 24 h UAC is shown in
Figure 2 and the association between ON UAC and 24 h
AER in Figure 3.
Again as expected, both ON and 24 h UAC showed
significant negative correlations with UF (Table 3). The
24 h UAC was positively associated with GFR and body
mass, while this was not the case for ON UAC. Men
tended to have higher 24 h UAC than women (P = 0.06),
but no difference was seen in ON UAC (Table 4). No
difference was seen between never-smokers and ever-
smokers.
A multiple regression analysis according to Equation 1
showed a significant negative association between UAC
and UF in 24 h (P = 0.002) and ON (P<0.001) samples.There were also positive associations with GFR (P = 0.005)
for 24 h UAC, but not significantly so for ON UAC
(P = 0.08). Ever-smokers had higher 24 h UAC (P = 0.049)
than never-smokers. There was no significant impact of age,
sex, or body mass.Albumin to creatinine concentration (ACR)
The 24 h ACR was significantly higher than ON ACR
(Table 2; regression equation: ON ACR = 0.15+0.58*24).
The association between ON ACR and 24 h AER is
shown in Figure 4. The 24 h ACR but not the ON ACR
was negatively correlated with the urinary creatinine
concentration (Table 3). The 24 h ACR was positively
correlated with GFR and negatively correlated with body
mass. The ON ACR was positively correlated with age
and negatively correlated with body mass. Both 24 h and




















24 h AER (mg/h)
Figure 1 Association between albumin excretion rate in
overnight and 24 h urine. Association between albumin excretion
rate (AER) in overnight (ON) and 24 h urine, both in mg/h. Regression line
is shown: ON AER=0.075+0.50 * 24 h AER. R
2=0.62, P<0.001. Hatched line:
line of identity. Note: Conversion factor for AER in mg/h to mg/d, *24.
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and ever-smokers.
In a multiple regression analysis according to Equation 1,
the associations with sex (higher in women; 24 h ACR:
P = 0.03; ON ACR P = 0.02) and GFR (24 h ACR:
P = 0.001; ON ACR P = 0.04) remained, while there was
no significant impact of age, body mass, or smoking.
ON UF was not significantly associated with ON ACR
(P = 0.09).
Albumin adjusted for specific gravity (ASG)
The 24 h and ON ASG were not significantly different
(Table 2). The associations between 24 h and ON ASG
on the one hand and the 24 h AER on the other were
similar to those for the corresponding UAC and ACR
measures (Table 3). No significant difference was seen
between men and women or between never-smokers
and ever-smokers (Table 4).
A multiple regression analysis according to Equation 1
showed a positive association between GFR and 24 h
ASG (P = 0.03). ON ASG was negatively associated with
UF (P = 0.01).
Discussion
The present study showed that AER was higher in 24 h
than in ON samples. ON samples may thus cause an
underestimation (about 25%) of the true albumin excretion
(Table 3 and Figure 1). To our knowledge, only twoprevious studies have examined diurnal variation of
albumin excretion in healthy subjects, both showing
lower excretion in ON samples [17,18]. The reason for
this difference may include daytime erect position (pos-
tural proteinuria) or physical exercise [18-21]. However,
Montagna et al. also found a variation independent of
posture and activity [18], which may be explained by
diurnal variation of GFR secondary to diurnal variation
in blood pressure [22,23].
We also found that 24 h AER was significantly positively
correlated with GFR, and there was a similar tendency for
ON AER. This finding is in agreement with rat experi-
ments by Ohlson et al. [24] Some authors have, however,
found that the glomerular filtration of albumin is relatively
independent of GFR, while the urinary excretion of albu-
min is more dependent on possible saturation of tubular
reabsorption [25]. An explanation of the different results
could be that we studied inter-individual variation in GFR
while Smithies discussed intra-individual variation [25].
AER was associated with body mass, in agreement
with previous studies showing an association between
24 h AER and BMI [5,26].
We found no significant association between AER and
UF. However, it has been shown that water loading does
increase AER, perhaps because the reuptake mecha-
nisms are less effective, or possibly because of increased
GFR due to increased blood pressure [27]. Our findings
suggest that this does not occur during physiological
variations in UF.
The 24 h AER was not significantly different in women
and men, while the ON AER was slightly higher in men.
The explanation may be the higher body mass in men,
since in the multiple regression model body mass, but
not sex, had a significant impact on AER.
There was no difference in AER between never-smokers
and ever-smokers, a finding in line with previous incon-
clusive studies [28]. We found no significant correlation
between AER and age, in agreement with most previous
studies [28,29].
The ON UAC was higher than 24 h UAC, despite the
fact that the AER was lower in ON than 24 h samples.
The difference between ON and 24 h UAC samples
must therefore have been caused by dilution (higher UF;
see Table 2). UAC was significantly positively correlated
with GFR in a multiple regression analysis, as was
AER.
The association between ON UAC and 24 h AER was
only moderate (R2 = 0.38, Figure 3), although the correl-
ation was not much lower than for ON ACR and ON ASG
(Table 3). This indicates that creatinine adjustment may
not be necessary if ON samples are used. ON UAC has
been suggested to replace ACR as screening method
[30-35]. The situation is different in daytime spot samples,
which may be much diluted.
Table 3 Spearman correlation coefficients between 24 h AER, proxies and determinants
24 h AER 24 h UAC 24 h ACR 24 h ASG ON AER ON UAC ON ACR ON ASG
24 h AER 1.00 0.77 0.77 0.71 0.61 0.40a 0.42b 0.40
<0.001 <0.001 <0.001 <0.001 <0.001 <0.001 <0.001
130 130 130 130 123 123 123 123
24 h UAC 0.77 1.00 0.63 0.69 0.57 0.60 0.42 0.48
<0.001 <0.001 <0.001 <0.001 <0.001 <0.001 <0.001
130 130 130 130 123 123 123 123
24 h ACR 0.77 0.63 1.00 0.75 0.44 0.31 0.67 0.41
<0.001 <0.001 <0.001 <0.001 .0005 <0.001 <0.001
130 130 130 130 123 123 123 123
24 h ASG 0.71 0.69 0.75 1.00 0.50 0.40 0.54 0.59
<0.001 <0.001 <0.001 <0.001 0.005 <0.001 <0.001
130 130 130 130 123 123 123 123
GFR 0.24 0.21 0.18 0.08 0.05 0.07 0.04 0.06
0.006 0.02 0.04 0.35 0.58 0.39 0.67 0.49
130 130 130 130 144 144 144 144
Sex −0.12 −0.17 0.33 0.07 −0.28 −0.09 0.21 0.08
0.16 0.06 <0.001 0.40 0.007 0.26 0.01 0.92
130 130 130 130 145 145 145 145
Body mass 0.17 0.21 −0.22 0.03 0.30 0.11 −0.14 0.09
0.04 0.02 0.01 0.79 <0.001 0.21 0.05 0.34
128 128 128 128 142 142 142 142
Smoking −0.04 −0.09 0.01 −0.15 −0.03 −0.08 0.05 −0.02
0.61 0.33 0.88 0.09 0.72 0.34 0.52 0.83
129 129 129 129 144 144 144 144
Age −0.08 0.06 0.06 −0.02 0.13 0.09 0.23 0.09
0.38 0.50 0.53 0.83 0.12 0.30 0.006 0.27
130 130 130 130 145 145 145 145
UF 0.06c −0.51c −0.006c −0.11c −0.03d −0.70d −0.18d −0.41d
0.47 <0.001 0.94 0.21 0.68 <0.001 0.04 <0.001
130 130 130 130 145 145 145 145
UCC 0.1e 0.54e −0.24e 0.05e 0.24f 0.71f −0.06f 0.35f
0.10 <0.001 0.005 0.56 0.04 <0.001 0.94 <0.001
130 130 130 130 145 145 145 145
Note: First row in each cell, spearman correlation coefficient; second row, P-value; third row, number of observations.
Abbreviations: ON Overnight, AER Albumin excretion rate, UAC Urinary albumin concentration, ASG Albumin adjusted for specific gravity, ACR Albumin to
creatinine ratio, GFR Glomerular filtration rate, UF Urinary flow, UCC Urinary creatinine concentration.
aMen: r=0.59, P<0.001, N=53; Women: r=0.24, P=0.043, N=70. bMen: r=0.64, P<0.001, N=53; Women: r=0.37, P=0.002, N=70. c24 h UF. dON UF. e24 h UCC. fON UCC.
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the corresponding difference seen for AER. ACR was
significantly positively correlated with GFR in a multiple
regression analysis, as was AER.
Random spot ACR have been used and there is evidence
that they can adequately predict 24 h urinary protein loss
in diabetics and others with kidney disease [9]. However,
there are no studies known to us that shows this in
healthy individuals. Previous studies have shown thatU-Alb varies not only between day and night, but dur-
ing the day as well, and this variability must be taken
into consideration when interpreting the results [9,36].
Overnight samples have a longer collection period than
day-time spot samples, and physical activity, posture
and intake of fluids varies less during the night than in
the day. Therefore we believe that ON samples are to
prefer over random day-time samples when evaluating
U-Alb. As expected, there was a significant difference
Table 4 Differences between men and women and between ever-smokers and never-smokers
Women Men Ever-smokers Never-smokers
Mean Mean Pa Mean Mean Pa
24 h AER (mg/24 h) 6.95 8.16 0.16 7.05 7.99 0.61
ON AER (mg/24 h) 5.59 6.19 <0.001 5.47 6.50 0.71
24 h UAC (mg/L) 3.93 4.80 0.06 3.91 4.90 0.33
ON UAC (mg/L) 6.51 6.10 0.26 5.69 7.42 0.34
24 h ACR (mg/g Cr) 6.37 5.13 0.001 5.81 5.84 0.09
ON ACR (mg/g Cr) 5.55 4.15 0.004 4.73 5.29 0.52
24 H ASG mg/L) 4.33 4.15 0.40 4.00 4.66 0.16
ON ASG (mg/L) 4.81 4.01 0.92 4.18 4.96 0.83
24 h UCC (g/L) 0.61 0.99 <0.001 1.20 0.87 0.03
ON UCC (g/L) 1.12 1.49 <0.001 1.02 1.42 0.04
24 h SG 1.014 1.018 <0.001 1.016 1.016 0.96
ON SG 1.019 1.023 0.008 1.020 1.022 0.12
Abbreviations: ON Overnight, AER Albumin excretion rate, UAC Urinary albumin concentration, ASG Albumin adjusted for specific gravity, ACR Albumin to creatinine
ratio, Cr Creatinine, GFR Glomerular filtration rate, UCC Urinary creatinine concentration, SG Specific gravity.
aWilcoxon rank sum test.
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http://www.biomedcentral.com/1471-2369/16/8in concentrations and excretion rates of creatinine (data
not shown) and ACR between men and women. This is
known to be caused by higher muscle mass in men
[37-39]. Although ON UF was positively correlated with
ON creatinine excretion rate, UF did not have any impact

















24 h UAC (mg/L)
Figure 2 Association between urinary albumin concentration in
overnight and 24 h urine. Association between urinary albumin
concentration (UAC) in overnight (ON) and 24 h urine, both in mg/L.
Regression line is shown: ON UAC=0.73+0.62 * 24 h UAC. R
2=0.46,
P<0.001. Hatched line: line of identity. Note: Conversion factor for
UAC in mg/L to g/dL, *10
−4.found to correlate with age [40,41], probably due to lower
muscle mass at higher age.
ON ACR, which is widely used for screening purposes,
showed a somewhat higher correlation with 24 h AER
(R2 = 0.44) than did ON UAC. ON ACR is relatively easy

















24 h AER (mg/h)
Figure 3 Association between overnight urinary albumin
concentration and 24 h albumin excretion rate. Association
between overnight urinary albumin concentration (ON UAC) and
24 h albumin excretion rate (24 h AER). Regression line is shown: ON
UAC=2.47+10.8 * 24 h AER. R
2=0.38, P<0.001. Note: Conversion factor
for UAC in mg/L to g/dL, *10






















24 h AER (mg/h)
Figure 4 Association between overnight urinary albumin to
creatinine ratio and 24 h albumin excretion rate. Association
between overnight urinary albumin to creatinine ratio (ON ACR) and
24 h albumin excretion rate (24 h AER). Regression line is shown: ON
ACR=0.23+0.96 * 24 h AER. R
2=0.44, P<0.001. Note: Conversion factor
for ACR in mg/mmol to mg/g, *8.84. Conversion factor for AER in
mg/h to mg/d, *24.
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[6,42-44]. Lambers Heerspink et al. showed that first
morning ACR was just as good as 24 h AER for prediction
of cardiovascular disease [42], and suggested that this may
be due to many errors in collection of 24 h samples. How-
ever, ACR may generate some falsely high ACR levels in
patients with low muscle mass and hence low creatinine
excretion [37]. ACR is a well-established measure, but
has not been studied in all populations, and most of the
available data are on diabetics.
There was no difference between 24 h and ON ASG,
probably because ON SG was significantly higher than
24 h SG (Table 2). Thus, adjusting for SG did not capture
the true difference between ON and 24 h AER.
ASG is sensitive to hematuria and glucosuria, since
they affect specific gravity [45,46]. On the other hand,
we found little or no correlation between ASG and other
variables in this study, such as age, sex, and body mass.
Although its routine use is rare, ASG could be used
instead of ACR, especially in situations where creatinine
excretion varies due to factors such as changes in body
composition and protein intake [47]. However, SG may be
affected by intake of certain food, like salt. Elkins et al. also
found that creatinine adjustment is more suitable for very
diluted or concentrated samples [46].
A strength of this study is the fact that separate ON
and 24 hour samples were collected; that is, the ONsample was not included in the 24 hour sample [10].
U-Alb is known to have intra-individual variation of
44-85 % (between days), depending on sample types
[40,48-50]. Despite this variability, we could show a differ-
ence between ON and 24 h samples collected on separate
days. If the ON sample had been a part of the 24 h sample,
we would have had better power to quantify differences
between ON and 24 h samples.
The samples were collected when the study subjects
were hospitalized, which reduced the risk of contamination
and collection errors. It is often recommended that very
concentrated (U-Crea>3 g/L) or dilute (U-Crea<0.3 g/L)
samples should be excluded, since the validity of such sam-
ples could be questioned. However, in the present study,
such urine samples were included, since one of the aims
was to study the impact of UF on albumin excretion.
The albumin concentrations were analyzed in fresh
urine samples. It has been shown that freezing and
thawing of urine can underestimate and increase the
variability of measured U-Alb.
Another strength is the fact that we had data on mea-
sured GFR. To the best of our knowledge, associations be-
tween GFR and U-Alb in healthy subjects have not been
reported previously. Estimated GFR (eGFR) is widely used,
and there are several different equations to obtain this
measure. It is however important to remember that while
it is useful for population studies, eGFR is a blunt tool for
use in individual patients.
A limitation is the fact that the study was performed on
kidney donors, who are somewhat ‘more healthy’ that a
general population sample. People with diabetes, hyperten-
sion, or kidney disease were not included in our sample.
On the other hand, as shown in Table 1, our sample was
diverse enough to include a person of 70 years of age and a
long-term heavy smoker.
Conclusions
The 24 h AER is the gold standard, even though other
measures of U-Alb may work relatively well. ON AER will
underestimate the 24-hour albumin excretion, probably
due to nocturnal hypotension and subsequent reduction
of glomerular filtration pressure. In addition, GFR and
body mass are positively associated with AER and ACR.
The differences between the various estimates of albumin
excretion are large enough to be worth considering in
scientific studies in healthy adults.
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